Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem … – Marketwired (press release)
|
Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem …
Marketwired (press release) SUNRISE, FL–(Marketwired – Sep 23, 2013) – Bioheart, Inc. ( OTCQB : BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage as well as … BIOHEART, INC. : BIOHEART BOOSTS TEAM WITH REGULATORY, FINANCE …4-traders (press release) |
